Par-4, a pro-apoptotic gene, inhibits radiation-induced NF kappa B activity and Bcl-2 expression leading to induction of radiosensitivity in human prostate cancer cells PC-3

Cancer Biol Ther. 2002 Mar-Apr;1(2):152-60. doi: 10.4161/cbt.61.

Abstract

Ionizing radiation caused induction NF kappa B activity and Bcl-2 protein expression in the radioresistant p53 null human prostate cancer cell line, PC-3. Exposure of PC-3 cells to Ad5-I kappa B super-repressor inhibited radiation-induced Bcl-2 expression indicating that radiation-induced NF kappa B activity is required for the induction of Bcl-2 protein. PAR-4, a novel pro-apoptotic protein is a potent down-modulator of NF kappa B activity and bcl-2 protein expression. This study was undertaken to investigate the impact of PAR-4 expression on radiation-induced NF kappa B activity and Bcl-2 expression and its resultant radiation response in PC-3 cells. Western blot analysis indicated that enforced expression of PAR-4 in PC-3 cells down regulated radiation-induced bcl-2 protein, whereas in vector transfected cells radiation caused an induction of bcl-2 protein. In both transfectant cell lines, the bax protein levels remained unaltered after radiation. When compared to PC-3/Vector cells, PC-3/PAR-4 cells showed significant sensitivity to radiation-induced clonogenic inhibition and apoptosis. Thus, the down-regulation of bcl-2 protein by ectopic PAR-4 expression altered bcl-2: bax ratio in PC-3/PAR-4 cells and this led enhanced radiosensitivity. PAR-4 was found to inhibit the radiation-induced NF kappa B activity and NF kappa B transcriptional activity is essential for bcl-2 upregulation. In PC-3/Vector cells, radiation caused an increase in NF kappa B activity leading to upregulation of bcl-2 protein. However, in PC-3/PAR-4 cells, the radiation-induced NF kappa B activity was inhibited resulting in the transrepression of bcl-2 promoter and down-modulation of bcl-2 protein. In addition, PAR-4 was found to directly inhibit the phosphorylation and degradation of I kappa B alpha, which led to the loss of NF kappa B activity causing repression of endogenous and radiation-induced Bcl-2 protein. Together, these mechanisms suggest that PAR-4 is functionally required to cause radiation-induced apoptosis by abrogating the survival and anti-apoptotic effects of NF kappa B activity and bcl-2 function respectively.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Apoptosis Regulatory Proteins
  • Apoptosis*
  • Carrier Proteins / genetics*
  • DNA-Binding Proteins / metabolism
  • Gene Expression Regulation / radiation effects
  • Humans
  • I-kappa B Proteins*
  • Intracellular Signaling Peptides and Proteins*
  • Male
  • NF-KappaB Inhibitor alpha
  • NF-kappa B / antagonists & inhibitors*
  • NF-kappa B / radiation effects
  • Phosphorylation
  • Prostatic Neoplasms / metabolism
  • Prostatic Neoplasms / pathology
  • Prostatic Neoplasms / radiotherapy*
  • Proto-Oncogene Proteins c-bcl-2 / antagonists & inhibitors*
  • Proto-Oncogene Proteins c-bcl-2 / radiation effects
  • Radiation Tolerance*
  • Tumor Cells, Cultured
  • Up-Regulation

Substances

  • Apoptosis Regulatory Proteins
  • Carrier Proteins
  • DNA-Binding Proteins
  • I-kappa B Proteins
  • Intracellular Signaling Peptides and Proteins
  • NF-kappa B
  • NFKBIA protein, human
  • Proto-Oncogene Proteins c-bcl-2
  • prostate apoptosis response-4 protein
  • NF-KappaB Inhibitor alpha